Ogen .625 Tab-Pak Estrogen Pill

<< >>
Description (Brief)
The popularity of “the Pill” created a new market for pharmaceutical companies. For the first time, healthy women would be taking medication for an extended period of time. Pill manufacturers developed unique packaging in order to distinguish their product from those of their competitors and build brand loyalty. Packaging design often incorporated a “memory aid” to assist women in tracking their daily pill regimen, as well as styled cases to allow pills to be discreetly carried in bags and purses. The National Museum of American History’s Division of Medicine and Science’s collection of oral contraceptives illustrates some of the changes that the packaging and marketing of the Pill underwent from its inception in 1960 to the present.
Abbott Laboratories of Chicago, Illinois, produced this Ogen .625 brand estrogen hormonal treatment around 1977. The yellow, blue, and orange packaging has a cutout to reveal a sample pill. The 21 pills are contained in a trapezoidal blister pack inside a yellow trapezoidal blister pack holder. The holder has the days of the week embossed around the perimeter. These pills contain .625 mg of sodium estrone sulfate.
Currently not on view
Abbott Laboratories
place made
United States: Illinois, North Chicago
Physical Description
piperazine estrone sulfate, .75 mg (drug active ingredients)
paper (packaging material)
plastic (packaging material)
foil (packaging material)
overall: 14.6 cm x 5.6 cm x .5 cm; 5 3/4 in x 2 3/16 in x 3/16 in
overall, pill packet: 2 1/2 in x 5 3/4 in x 3/8 in; 6.35 cm x 14.605 cm x .9525 cm
overall, leaflet: 6 in x 13 5/8 in; 15.24 cm x 34.6075 cm
ID Number
accession number
catalog number
Credit Line
Gift of Gladys Abell and Lester D. Johnson, Jr., M.D.
Birth Control/Contraception
See more items in
Medicine and Science: Medicine
Birth Control
Health & Medicine
Data Source
National Museum of American History


Add a comment about this object